Wilmington, Delaware, United States, Transparency Market Research Inc. – Drug delivery devices are specialized tools used for the delivery of a drug or therapeutic agent through a specific route of administration.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Drug delivery devices are specialized tools used for the delivery of a drug or therapeutic agent through a specific route of administration. The devices are used one or more than one times for medical treatments. Drug delivery devices present unique challenges in all aspects of product development from regulatory strategy to design and material considerations through devising and implementing testing methodologies.
Read Report Overview - https://www.transparencymarketresearch.com/drug-delivery-devices-market.html
Drug delivery is an important method of administration of pharmaceutical compounds, which achieve therapeutic effect in humans or animals. A rise in the number of diabetes patients and an increase in the incidence of cancer and respiratory diseases are driving the use of drug delivery devices among patients and physicians.
According to the Indian Council of Medical Research, diabetes mellitus has become a growing problem in the contemporary world. India has become the diabetes capital of the world. There are over 20 million diabetes patients in the country, and the number is likely to increase to 57 million by 2025. Moreover, development of nanotechnology, radiotherapy devices, and digital mode devices are likely to propel the drug delivery devices market. This is expected to create a significant opportunity in the pharmaceutical and medical device market during the next few years.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63609
The global drug delivery devices market is driven by rapid development in technology, increase in funding for drug research, changing lifestyles, rise in patient preference for drug delivery devices, and increase in government support for research & development. Moreover, a rise in the prevalence of diabetes, which leads to hyperglycemia, is expected to drive the drug delivery devices market.
Additionally, a rise in the number of patients preferring the use of new drug-delivery systems needed to support patient mobility is estimated to augment the market in the near future. However, high cost of research & development and devices, high maintenance cost, and introduction of alternate therapy in oC
The drug delivery devices market can be segmented based on application, device, route of administration, distribution channel, and geography. In terms of application, the drug delivery devices market can be classified into type diabetes, cancer, respiratory disease, and others. Based on device, the drug delivery devices market can be categorized into syringes, inhalers, patch pumps, and others. In terms of route of administration, the drug delivery devices market can be classified into topical, transmucosal, inhalation, and injection. Based on distribution channel, the drug delivery devices market can be divided into hospital pharmacies, retail pharmacies, and e-commerce.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=63609
In terms of geography, the drug delivery devices market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global drug delivery devices market due to the availability of different types of approvals and funding from government in the research & development of drugs. Additionally, physicians’ preference for drug delivery devices over other therapy is driving the medical biotechnology and pharmaceutical market. This, in turn, is expected to drive the drug delivery devices market in North America.
Europe is a prominent region of the drug delivery devices market due to favorable government policies regarding health care infrastructure; high incidence of chronic diseases due to environmental conditions; and rise in awareness about diabetes, cancer, and other major chronic diseases.
The market in Asia Pacific is expected to expand at a rapid rate due to a rise in demand for drug delivery products from the diabetic population, rise in the incidence of diabetes due a rise in the geriatric population, changing lifestyles, increase in the prevalence of chronic diseases, and rise in awareness among patients about special administration drugs.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=63609
In addition, economic growth is supporting the improvement of health care infrastructure in developing countries such as South Africa, Israel, and Brazil. This is projected to propel the drug delivery devices market in Middle East & Africa and Latin America region during the next few years.
Major players operating in the global drug delivery devices market are Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Nemera, Biocorp Production, Valeritas Holdings Inc., Ethicon, Eli Lilly and Co., Accord Healthcare Ltd., PharmaC LLC, and other significant players worldwide.
More Trending Reports by Transparency Market Research –
Eye Care Surgical Devices Market: The global eye care surgical devices market is anticipated to reach US$ 10.7 Bn by the end of 2031.
Smart Fertility Tracker Market: The global smart fertility tracker market is anticipated to reach US$ 428.2 Mn by 2031. The global market is projected to expand at a CAGR of 10.7% from 2022 to 2031.
Radiation Therapy Market: The global radiation therapy market is anticipated to reach US$ 10.6 Bn by the end of 2031. The global market is projected to grow at a CAGR of 5.4% from 2022 to 2031.
Vascular Graft Market: The global vascular graft market is anticipated to reach US$ 4.7 Bn by the end of 2031. The global market is projected to expand at a CAGR of 5.3% from 2022 to 2031.
Heart Valve Devices Market: The global heart valve devices market is anticipated to reach US$ 26.3 Bn by the end of 2031. The global market is projected to grow at a CAGR of 11.9% from 2022 to 2031.
Sinus Dilation Devices Market: The global sinus dilation devices market is anticipated to reach US$ 4.7 Bn by 2031. The global market is projected to grow at a CAGR of 7.2% from 2022 to 2031.
Electrophysiology Devices Market: The global electrophysiology devices market is anticipated to reach US$ 14.8 Bn by the end of 2031.
Mobility Aid Devices Market: The mobility aid devices market is expected to reach value of US$ 15.6 Bn by the end of 2031. It is estimated to advance at a CAGR of 5.1% from 2022 to 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com